Jpmorgan Chase & CO Celcuity Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Celcuity Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 15,619 shares of CELC stock, worth $185,866. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,619

Previous 14,683 6.37%

Holding current value

$185,866

Previous $192,000 18.23%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$8.62 - $13.62 $8,068 - $12,748	936 Added 6.37%	15,619 $157,000
Q4 2024 Feb 12, 2025	BUY	$12.0 - $16.35 $32,112 - $43,752	2,676 Added 22.29%	14,683 $192,000
Q3 2024 Dec 26, 2024	SELL	$13.98 - $19.15 $162,335 - $222,369	-11,612 Reduced 49.16%	12,007 $179,000
Q3 2024 Nov 08, 2024	SELL	$13.98 - $19.15 $162,335 - $222,369	-11,612 Reduced 49.16%	12,007 $179,000
Q2 2024 Dec 26, 2024	BUY	$14.1 - $20.78 $163,729 - $241,297	11,612 Added 96.71%	23,619 $386,000
Q2 2024 Aug 12, 2024	SELL	$14.1 - $20.78 $500,479 - $737,586	-35,495 Reduced 60.04%	23,619 $386,000
Q1 2024 Dec 26, 2024	BUY	$13.74 - $21.6 $647,250 - $1.02 Million	47,107 Added 392.33%	59,114 $1.28 Million
Q1 2024 May 10, 2024	BUY	$13.74 - $21.6 $578,014 - $908,668	42,068 Added 246.79%	59,114 $1.28 Million
Q4 2023 Dec 26, 2024	BUY	$8.7 - $15.02 $43,839 - $75,685	5,039 Added 41.97%	17,046 $248,000
Q4 2023 Feb 12, 2024	BUY	$8.7 - $15.02 $45,292 - $78,194	5,206 Added 43.97%	17,046 $248,000
Q3 2023 Nov 14, 2023	SELL	$8.96 - $10.75 $13,628 - $16,350	-1,521 Reduced 11.38%	11,840 $108,000
Q2 2023 Aug 11, 2023	BUY	$9.39 - $12.18 $116,238 - $150,776	12,379 Added 1260.59%	13,361 $146,000
Q1 2023 May 11, 2023	SELL	$9.4 - $12.82 $37,487 - $51,126	-3,988 Reduced 80.24%	982 $10,000
Q4 2022 Feb 13, 2023	BUY	$7.55 - $14.01 $37,523 - $69,629	4,970 New	4,970 $70,000
Q2 2022 Aug 11, 2022	SELL	$5.35 - $10.11 $24,262 - $45,848	-4,535 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$7.93 - $13.33 $6,558 - $11,023	827 Added 22.3%	4,535 $42,000
Q4 2021 Feb 10, 2022	SELL	$11.96 - $19.35 $44,072 - $71,304	-3,685 Reduced 49.84%	3,708 $49,000
Q3 2021 Nov 12, 2021	BUY	$17.35 - $24.87 $128,268 - $183,863	7,393 New	7,393 $133,000

Others Institutions Holding CELC

# of Institutions

Shares Held

30.6M

Call Options Held

16.2K

Put Options Held

51.9K

View Full List

About Celcuity Inc.

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $178M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

More about CELC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Celcuity Inc. Transaction History